Marialucia Gallorini

Dr. Marialucia Gallorini

Department of Pharmacy, University of Chieti-Pescara
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Biomaterials
Verified
Journal Article
Closed access
Marialucia GalloriniMarialucia Gallorini
Marialucia Gallorini
CPChristine Petzel
Christine Petzel
CBCarola Bolay
Carola Bolay
KHKarl-Anton Hiller
Karl-Anton Hiller
ACAmelia Cataldi
Amelia Cataldi
HSHelmut Schweikl
Helmut Schweikl

4 August 2015 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
SSSilvia Sancilio
Silvia Sancilio
Marialucia GalloriniMarialucia Gallorini
Marialucia Gallorini
ACAmelia Cataldi
Amelia Cataldi
Viviana di GiacomoViviana di Giacomo
Viviana di Giacomo

28 January 2014 in International Endodontic Journal
Verified
Journal Article
Closed access
PDF file
Marialucia GalloriniMarialucia Gallorini
Marialucia Gallorini
ACA. Cataldi
A. Cataldi
Viviana di GiacomoViviana di Giacomo
Viviana di Giacomo

2 August 2018 in Stem Cells International
Verified
Journal Article
Open access
PDF file
SSSilvia Sancilio
Silvia Sancilio
Marialucia GalloriniMarialucia Gallorini
Marialucia Gallorini
CNChiara Di Nisio
Chiara Di Nisio
Eleonora MarsichEleonora Marsich
Eleonora Marsich
Roberta Di PietroRoberta Di Pietro
Roberta Di Pietro
ACAmelia Cataldi
Amelia Cataldi
Tissue engineering is widely recognized as a promising approach for bone repair and reconstruction. Several attempts have been made to achieve materials that must be compatible, osteoconductive, and osteointegrative and have mechanical strength to provide a structural support. Composite scaffolds consisting in biodegradable natural polymers are very promising constructs. Hydroxyapatite (HAp) can support alginate as inorganic reinforcement and osteoconductive component of alginate/HAp composite scaffolds. Therefore, HAp-strengthened polymer biocomposites offer a solid system to engineer synthetic bone substitutes. In the present work, HAp was incorporated into an alginate solution and internal gelling was induced by addition of slowly acid-hydrolyzing D-gluconic acid delta-lactone for the direct release of calcium ions from HAp. It has been previously demonstrated that alginate-based composites efficiently support adhesion of cancer bone cell lines. Human dental pulp stem cells (DPSCs) identified in human dental pulp are clonogenic cells capable of differentiating in multiple lineage. Thus, this study is aimed at verifying the mineralization and differentiation potential of human DPSCs seeded onto scaffolds based on alginate and nano-hydroxyapatite. For this purpose, gene expression profile of early and late mineralization-related markers, extracellular matrix components, viability parameters, and oxidative stress occurrence were evaluated and analyzed. In summary, our data show that DPSCs express osteogenic differentiation-related markers and promote calcium deposition and biomineralization when growing onto Alg/HAp scaffolds. These findings confirm the use of Alg/HAp scaffolds as feasible composite materials in tissue engineering, being capable of promoting a specific and successful tissue regeneration as well as mineralized matrix deposition and sustaining natural bone regeneration.

23 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Osama ElsallabiOsama Elsallabi
Osama Elsallabi
Antonia PatrunoAntonia Patruno
Antonia Patruno
MPMirko Pesce
Mirko Pesce
Amelia CataldiAmelia Cataldi
Amelia Cataldi
Simone CarradoriSimone Carradori
Simone Carradori
Marialucia GalloriniMarialucia Gallorini
Marialucia Gallorini
Like other organs, brain functions diminish with age. Furthermore, for a variety of neurological disorders—including Alzheimer’s disease—age is one of the higher-risk factors. Since in many Western countries the average age is increasing, determining approaches for decreasing the effects of aging on brain function is taking on a new urgency. Neuroinflammation and oxidative stress are two convoluted key factors in brain aging and chronic neurodegenerative diseases. The diverseness of factors, causing an age-related decrease in brain functions, requires identifying small molecules that have multiple biological activities that can affect all these factors. One great source of these small molecules is related to polyphenolic flavonoids. Recently, 3,3′,4′,7-tetrahydroxyflavone (fisetin) has been reported as a potent senotherapeutic capable of extending lifespan by reducing peroxidation levels and enhancing antioxidant cell responses. The neuroprotective effects of fisetin have been shown in several in vitro and in vivo models of neurological disorders due to its actions on multiple pathways associated with different neurological disorders. The present work aims to collect the most recent achievements related to the antioxidant and neuroprotective effects of fisetin. Moreover, in silico pharmacokinetics, pharmacodynamics, and toxicity of fisetin are also comprehensively described along with emerging novel drug delivery strategies for the amelioration of this flavonol bioavailability and chemical stability.

1 January 2020 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MARIALUIGIA FANTACUZZIMARIALUIGIA FANTACUZZI
MARIALUIGIA FANTACUZZI
BFBarbara De Filippis
Barbara De Filippis
Marialucia GalloriniMarialucia Gallorini
Marialucia Gallorini
AAAlessandra Ammazzalorso
Alessandra Ammazzalorso
Letizia GiampietroLetizia Giampietro
Letizia Giampietro
Rosa AmorosoRosa Amoroso
Rosa Amoroso